Mauri MC - Search Results

1

Clinical outcome and tolerability of duloxetine in the treatment of major depressive disorder: a 12-week study with plasma levels.

Volonteri LS, Colasanti A, Cerveri G, Fiorentini A, De Gaspari IF, Mauri MC, Valli A, Papa P, Mencacci C. Volonteri LS, et al. Among authors: mauri mc. J Psychopharmacol. 2010 Aug;24(8):1193-9. doi: 10.1177/0269881109104863. Epub 2009 Apr 30. J Psychopharmacol. 2010. PMID: 19406851

2

Long-acting injectable risperidone and metabolic ratio: a possible index of clinical outcome in treatment-resistant schizophrenic patients.

Volonteri LS, Cerveri G, De Gaspari IF, Baldi ML, Rolandi ML, Papa P, Mauri MC, Mencacci C. Volonteri LS, et al. Among authors: mauri mc. Psychopharmacology (Berl). 2010 Jul;210(4):489-97. doi: 10.1007/s00213-010-1852-5. Epub 2010 Apr 27. Psychopharmacology (Berl). 2010. PMID: 20422405 Clinical Trial.

3

Duloxetine in elderly major depression disorder: effectiveness and drug plasma level evaluation.

Rovera C, Mauri MC, Bertin E, Di Pace C, Paletta S, Reggiori A, De Gaspari IF, Cattaneo D, Mari D, Altamura AC. Rovera C, et al. Among authors: mauri mc. Hum Psychopharmacol. 2016 Sep;31(5):349-55. doi: 10.1002/hup.2544. Epub 2016 Jul 12. Hum Psychopharmacol. 2016. PMID: 27400882 Clinical Trial.

4

Clinical outcome and tolerability of sertraline in major depression: a study with plasma levels.

Mauri MC, Laini V, Cerveri G, Scalvini ME, Volonteri LS, Regispani F, Malvini L, Manfré S, Boscati L, Panza G. Mauri MC, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2002 Apr;26(3):597-601. doi: 10.1016/s0278-5846(01)00314-1. Prog Neuropsychopharmacol Biol Psychiatry. 2002. PMID: 11999914

5

Long-term efficacy and therapeutic drug monitoring of sertraline in major depression.

Mauri MC, Fiorentini A, Cerveri G, Volonteri LS, Regispani F, Malvini L, Boscati L, Baido RL, Invernizzi G. Mauri MC, et al. Hum Psychopharmacol. 2003 Jul;18(5):385-8. doi: 10.1002/hup.502. Hum Psychopharmacol. 2003. PMID: 12858326 Clinical Trial.

6

Predictors of clinical outcome in schizophrenic patients responding to clozapine.

Mauri MC, Volonteri LS, Dell'Osso B, Regispani F, Papa P, Baldi M, Bareggi SR. Mauri MC, et al. J Clin Psychopharmacol. 2003 Dec;23(6):660-4. doi: 10.1097/01.jcp.0000095351.32154.3a. J Clin Psychopharmacol. 2003. PMID: 14624196

7

Two weeks' quetiapine treatment for schizophrenia, drug-induced psychosis and borderline personality disorder: a naturalistic study with drug plasma levels.

Mauri MC, Volonteri LS, Fiorentini A, Pirola R, Bareggi SR. Mauri MC, et al. Expert Opin Pharmacother. 2007 Oct;8(14):2207-13. doi: 10.1517/14656566.8.14.2207. Expert Opin Pharmacother. 2007. PMID: 17927477

8

Clinical outcome and olanzapine plasma levels in acute schizophrenia.

Mauri MC, Steinhilber CP, Marino R, Invernizzi E, Fiorentini A, Cerveri G, Baldi ML, Barale F. Mauri MC, et al. Eur Psychiatry. 2005 Jan;20(1):55-60. doi: 10.1016/j.eurpsy.2004.09.009. Eur Psychiatry. 2005. PMID: 15642445 Clinical Trial.

9

Ziprasidone outcome and tolerability: a practical clinical trial with plasma drug levels.

Mauri MC, Colasanti A, Rossattini M, Volonteri LS, Dragogna F, Fiorentini A, Fiorentini A, Valli A, Papa P. Mauri MC, et al. Pharmacopsychiatry. 2007 May;40(3):89-92. doi: 10.1055/s-2007-973835. Pharmacopsychiatry. 2007. PMID: 17541882 Clinical Trial.

10

Safety of SSRIs during pregnancy: a controlled study.

Altamura AC, De Gaspari IF, Rovera C, Colombo EM, Mauri MC, Fedele L. Altamura AC, et al. Among authors: mauri mc. Hum Psychopharmacol. 2013 Jan;28(1):25-8. doi: 10.1002/hup.2276. Epub 2012 Nov 20. Hum Psychopharmacol. 2013. PMID: 23166037 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

117 results

Search Page

Filters